The median values of FGF19 and FGF21 were significantly lower in NASH− and NASH+ children vs. controls and lower in NASH+ children compared to NASH− children (p<0.001 for all comparisons, quantile regression with Bonferroni’s correction) (Figure 1, panel B). Here, FGF19 is linked to metabolic dysfunction-associated steatohepatitis.